Board Member
Fennec Pharmaceuticals Inc. (FENC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jeffrey S. Hackman is recorded as CEO and Board Member at Fennec Pharmaceuticals Inc. (FENC). Fennec Pharmaceuticals Inc. reported in an 8-K filed August 7, 2024 that Jeffrey S. Hackman was appointed member of the Board, effective August 5, 2024. Fennec Pharmaceuticals Inc. reported in an 8-K filed August 7, 2024 that Jeffrey S. Hackman was appointed Chief Executive Officer, effective August 5, 2024. Jeffrey S. Hackman has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Fennec Pharmaceuticals Inc. on August 11, 2026.
“On August 5, 2024, the Company announced the appointment of Jeffrey S. Hackman as CEO and a member of the Board.”
“On August 5, 2024, the Company announced the appointment of Jeffrey S. Hackman as CEO and a member of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-08-05–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2024-08-05–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
